ImpediMed Limited IPDQF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.51% | -12.61% | -12.27% | -13.18% | -15.81% |
| Total Depreciation and Amortization | -50.24% | -62.95% | -67.81% | -49.27% | 12.04% |
| Total Amortization of Deferred Charges | 4.86% | 43.69% | 129.99% | 129.99% | 129.99% |
| Total Other Non-Cash Items | 231.47% | 1,603.65% | 207.54% | 213.73% | 224.38% |
| Change in Net Operating Assets | -154.08% | -65.08% | 168.54% | 168.54% | 168.54% |
| Cash from Operations | -20.06% | -0.96% | 14.81% | 14.68% | 13.42% |
| Capital Expenditure | -23.95% | -126.06% | -- | -43.94% | 28.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,479.35% | 73.85% | 107.84% | 103.49% | 101.25% |
| Cash from Investing | -2,815.04% | 66.50% | 104.06% | 100.93% | 99.35% |
| Total Debt Issued | -51.93% | 96.15% | -- | -- | -- |
| Total Debt Repaid | -1,157.11% | -542.31% | 19.26% | 15.34% | 11.53% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -144.98% | -321.23% | -- | -8,379.03% | -2,969.35% |
| Cash from Financing | 2.40% | 162.47% | 4,286.08% | 3,540.53% | 2,840.14% |
| Foreign Exchange rate Adjustments | -290.80% | -431.38% | -253.32% | -249.40% | -231.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -169.45% | 72.53% | 105.21% | 96.19% | 87.43% |